Oct 6 : Arcutis Biotherapeutics is adding another indication for its psoriasis cream, Zoryve, after the FDA approved the companys supplemental New Drug Application (sNDA) to expand the treatment for children ages 6 to 11
He was also treated with UCT-MSC-EXs manufactured by Vitti Labs (Liberty, MO, USA)
Genetic factors affecting GLP-1 receptor density and sensitivity mean some people achieve therapeutic effects at 0.5mg while others need 2.4mg for comparable results
Jamie Alan, Ph.D., an associate professor of pharmacology and toxicology at Michigan State University, agrees that more research is needed
41 This finding was consistent with oral semaglutide, with mild-to-moderate gastrointestinal adverse events being the most commonly reported events in clinical trials
Surg Obes Relat Dis 21:689694 Abi Mosleh K, Salameh Y, Ghusn W et al (2024) Impact of metabolic and bariatric surgery on weight loss and insulin requirements in type 1 and insulin-treated type 2 diabetes